HL Genomics to hold extraordinary shareholders meeting to elect independent director Kim Bang-hyun

PUBT · 2d ago
HL Genomics to hold extraordinary shareholders meeting to elect independent director Kim Bang-hyun
  • HL Genomics will hold an extraordinary shareholders’ meeting on Nov. 27, 2026, at 10:00 a.m.
  • Agenda includes appointing independent director Kim Banghyun.
  • Shareholders will also vote on adopting an executive compensation policy.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HL Genomics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012900449), on October 12, 2026, and is solely responsible for the information contained therein.